Market Tracker

12/09 2:18pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

21.50
Delayed Data
As of 2:02pm ET
 +0.30 / +1.42%
Today’s Change
16.40
Today|||52-Week Range
43.63
-49.74%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close21.20
Today’s open21.25
Day’s range20.98 - 22.15
Volume231,830
Average volume (3 months)604,217
Market cap$977.6M
Dividend yield--
Data as of 2:02pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-81.44%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratioNM
Price/Sales3.79
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.05+0.38%
SGYPSynergy Pharmaceutic...-0.36-6.50%
MGNXMacroGenics Inc+0.28+1.03%
PTLAPortola Pharmaceutic...+0.42+2.31%
Data as of 2:18pm ET, 12/09/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.10
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts